Longeveron Inc.
جودة البيانات: 100%
LGVN
NASDAQ
Manufacturing
Chemicals
KWD 1.09
▼
KWD 0.03
(-2.68%)
القيمة السوقية: 32.50 M
6 months return
—
Momentum
Neutral
5Y revenue growth
-2.11%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -2.11% annually over 5 years
Negative free cash flow of -18.89 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 47.76%
Price History
النمو
Revenue Growth (5Y)
-2.11%
أقل من متوسط القطاع (1.72%)
Revenue (1Y)-49.87%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-200.72%
أقل من متوسط القطاع (-54.44%)
ROIC-152.78%
Net Margin-1893.58%
Op. Margin-1942.20%
الأمان
Debt / Equity
N/A
Current Ratio2.09
Interest CoverageN/A
التقييم
PE (TTM)
-1.43
أعلى من متوسط القطاع (-1.49)
P/B Ratio3.26
EV/EBITDAN/A
Dividend YieldN/A
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -1.4 | -1.5 |
| P/B | 3.3 | 1.6 |
| ROE % | -200.7 | -54.4 |
| Net Margin % | -1893.6 | -41.5 |
| Rev Growth 5Y % | -2.1 | 1.7 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
3 محللين
إجماع المحللين الذين يغطون السهم: متوسط الهدف مقارنة بالسعر الحالي وتصنيفهم.
Strong Buy
الحالي
KWD 1.09
المستهدف
KWD 5.48
KWD 2.00
KWD 4.00
KWD 10.45
التوقعات
ربحية السهم المستقبلية
-KWD 0.54
الإيرادات المقدّرة
7.71 M
تقديرات الأرباح
توقعات المحللين لربحية السهم والإيرادات حسب الفترة. السنوي = سنوات مالية؛ الفصلي = أرباع قريبة.
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.54
-KWD 0.90 – -KWD 0.34
|
7.71 M | 3 |
| FY2026 |
-KWD 0.40
-KWD 0.40 – -KWD 0.40
|
838,670.0 | 1 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.17
-KWD 0.20 – -KWD 0.12
|
268,670.0 | 3 |
| 2026 Q1 |
-KWD 0.17
-KWD 0.21 – -KWD 0.12
|
312,670.0 | 3 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.37 | -KWD 0.22 | +40.0% |
| Q32025 | -KWD 0.26 | -KWD 0.39 | -52.0% |
| Q22025 | -KWD 0.35 | -KWD 0.33 | +6.4% |
| Q12025 | -KWD 0.33 | -KWD 0.34 | -3.8% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -49.87% | Revenue Growth (3Y) | 30.04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2.11% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.20 M | Net Income (TTM) | -22.70 M |
| ROE | -200.72% | ROA | -140.56% |
| Gross Margin | 66.97% | Operating Margin | -1942.20% |
| Net Margin | -1893.58% | Free Cash Flow (TTM) | -18.89 M |
| ROIC | -152.78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.09 |
| Interest Coverage | N/A | Asset Turnover | 0.07 |
| Working Capital | 5.40 M | Tangible Book Value | 7.66 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.43 | Forward P/E | N/A |
| P/B Ratio | 3.26 | P/S Ratio | 27.11 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 4.21 | Fwd Earnings Yield | N/A |
| FCF Yield | -58.12% | ||
| Market Cap | 32.50 M | Enterprise Value | 23.26 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.29 | Revenue / Share | 0.04 |
| FCF / Share | -0.65 | OCF / Share | -0.64 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 20.43% | FCF Conversion | 83.20% |
| SBC-Adj. FCF | -21.60 M | Growth Momentum | -47.76 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.20 M | 2.39 M | 709,000.0 | 1.22 M | 1.31 M |
| Net Income | -22.70 M | -15.97 M | -21.41 M | -18.84 M | -17.05 M |
| EPS (Diluted) | -1.29 | -2.62 | -1.02 | -0.90 | — |
| Gross Profit | 803,000.0 | 1.88 M | 221,000.0 | 497,000.0 | 590,000.0 |
| Operating Income | -23.29 M | -16.52 M | -21.03 M | -18.04 M | -17.46 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 12.04 M | 8.14 M | 9.07 M | 9.37 M | 7.09 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 800,000.0 | 700,000.0 | 700,000.0 | 0.7 | 0.7 |
| Interest Expense | — | — | — | 1.40 M | 4,000.0 |
| Income Tax | 0.0 | 0.0 | 0.0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10.26 M | 25.56 M | 12.08 M | 27.41 M | 42.77 M |
| Total Liabilities | 4.59 M | 3.67 M | 5.34 M | 6.91 M | 5.31 M |
| Shareholders' Equity | 5.68 M | 21.89 M | 6.74 M | 20.50 M | 37.45 M |
| Total Debt | — | — | — | — | 311,000.0 |
| Cash & Equivalents | 4.66 M | 19.23 M | 4.95 M | 10.50 M | 25.66 M |
| Current Assets | 5.45 M | 19.62 M | 5.85 M | 20.28 M | 35.38 M |
| Current Liabilities | 4.09 M | 2.58 M | 3.89 M | 4.87 M | 2.71 M |
{"event":"ticker_viewed","properties":{"ticker":"LGVN","listing_kind":"stock","pathname":"/stocks/lgvn","exchange":"NASDAQ","country":"US"}}